Welcome to our dedicated page for Constellium Se SEC filings (Ticker: CSTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Constellium SE (NYSE: CSTM) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. As an NYSE‑listed issuer of ordinary shares, Constellium submits periodic and current reports that describe its financial condition, segment performance, governance changes and other material events.
Among the most relevant documents for investors are current reports on Form 8‑K. Constellium uses Form 8‑K to announce results of operations and financial condition under Item 2.02, typically in connection with quarterly earnings releases and investor presentations. These filings reference detailed press releases and slide decks that include shipments, revenue, net income, Adjusted EBITDA, Segment Adjusted EBITDA for the Aerospace & Transportation (A&T), Packaging & Automotive Rolled Products (P&ARP) and Automotive Structures & Industry (AS&I) segments, as well as the impact of metal price lag.
Constellium also files 8‑Ks under Item 5.02 to disclose departures and appointments of directors and certain officers and related compensatory arrangements. For example, the company has reported the Board’s decision to appoint Ingrid Joerg as Chief Executive Officer and director, effective January 1, 2026, and has outlined the key terms of her employment agreement. The same filing describes the planned transition of Jean‑Marc Germain to a Special Advisor role and summarizes his transition agreement.
Over time, investors can also review annual reports on Form 10‑K and quarterly reports on Form 10‑Q (when available) to analyze Constellium’s consolidated financial statements, risk factors, segment information, discussion of metal price lag and explanations of trends in its aerospace, packaging, automotive and industrial businesses. Forms 3, 4 and 5, when filed, provide data on insider holdings and changes in ownership by directors and officers.
Stock Titan enhances these filings with AI-powered summaries that explain key points in plain language, highlight important changes from prior periods and draw attention to items such as segment performance, leverage metrics, share repurchases, leadership changes and compensation arrangements. Real-time updates from EDGAR help ensure that new CSTM filings, including 10‑K, 10‑Q, 8‑K and insider transaction reports, appear promptly so users can review the underlying documents and AI insights in one place.
Constellium SE files an Annual Report on Form 10-K describing its global aluminum manufacturing business, strategy, and risks while reporting full-year 2025 non-GAAP and balance-sheet metrics. The company reports Adjusted EBITDA of $846 million and Net income $275 million for the year ended December 31, 2025, and states Free Cash Flow of $178 million for 2025.
The filing explains metal-price pass-through and hedging practices, details segment organization (A&T, P&ARP, AS&I), highlights operational footprint (24 manufacturing sites, 3 R&D centers), discloses 135,069,771 outstanding shares as of January 30, 2026, and describes key risks including customer concentration, supply chain and energy-price exposure, climate and regulatory risks, and labor/quality dependency.
Constellium SE outlines 16 proposals for its 2026 Annual General Meeting on May 21, 2026 in Paris, covering board elections, executive pay, financial statements and capital actions. Shareholders as of May 13, 2026 on the French Register date will be entitled to vote one vote per ordinary share.
The board seeks to ratify and elect CEO Ingrid Joerg as director for a three‑year term, reappoint director John Ormerod, and approve 2025 compensation for named executive officers on an advisory basis. It recommends holding the say‑on‑pay vote every year.
Shareholders are asked to approve statutory 2025 parent‑company financial statements showing a net loss of €7,184,045.19 and consolidated Group net income of $257 million, discharge directors and auditors, and allocate the loss against retained earnings with no dividend. The board also proposes raising the aggregate cap on non‑executive director fees and renewing authorizations to repurchase shares and cancel repurchased shares, enabling potential share capital reductions under French law.
CONSTELLIUM SE senior vice president and Chief Innovation Officer Jarrett Martin filed an initial Form 3 detailing his equity holdings in the company. He reports beneficial ownership of 20,091 ordinary shares as of April 1, 2026, consisting of 9,554 ordinary shares held directly and 10,537 restricted stock units that are still subject to vesting restrictions. This filing records his starting ownership position as an officer rather than reporting a new stock purchase or sale.
Constellium SE has filed a preliminary Proxy Statement for its 2026 Annual General Meeting to be held on May 21, 2026. The Board asks shareholders to vote on sixteen resolutions including ratification and re-appointment of directors, advisory votes on executive compensation frequency, approval of statutory and consolidated financial statements, discharge of directors, authorization for share repurchases under French law, and increases to the aggregate cap on directors’ annual fixed fees. The statutory accounts show a Company net loss of €7,184,045.19 and the Group consolidated net income of $257 million for the year ended December 31, 2025. The Proxy Statement will be first made available on or about April 10, 2026, with U.S. and French record dates of April 1, 2026 and May 13, 2026, respectively.
Constellium SE senior vice president and chief procurement officer Marcus Becker sold 10,000 ordinary shares in an open-market transaction. The shares were sold at a weighted average price of $25.09 per share, with individual trade prices ranging from $25.08 to $25.11. Following this sale, he continues to directly own 27,175 ordinary shares of Constellium SE.
CONSTELLIUM SE director Jean-Christophe Deslarzes bought 1,665 ordinary shares in the open market. The purchase took place on March 2, 2026 at a price of $24.77 per share. After this transaction, he directly owns 40,700 ordinary shares of Constelium.
Constellium SE reports Rule 144 transactions in Common Stock: a sale of 15,570 shares on 02/20/2026 for $398,269.75 and a sale of 1,113 shares on 03/10/2026 for $28,796.79. The filing also lists RSU and PSU issuances of 6,912 and 14,592 shares respectively, dated 03/13/2026.
CONSTELLIUM SE reported that SVP GC & Secretary Stephen Charles Walters received a grant or award of 5,834 ordinary shares on 2026-03-12. Following this acquisition, he directly owns a total of 25,068 ordinary shares.
Weiler Wiebke reported acquisition or exercise transactions in this Form 4 filing.
CONSTELLIUM SE director Wiebke Weiler received an equity grant tied to future service. The filing reports an award of 625 ordinary-share-based restricted stock units, which vest in full on March 12, 2029, subject to the director’s continued employment. Following this grant, Weiler’s reported direct holdings total 625 shares.
Brun Nicolas reported acquisition or exercise transactions in this Form 4 filing.
CONSTELLIUM SE senior vice president Nicolas Brun reported an equity compensation award rather than a market purchase. He received 4,376 ordinary shares in the form of restricted stock units that were granted at no cash cost. These units vest in full on March 12, 2029, subject to his continued employment. Following this award, he is shown as holding 131,552 ordinary shares directly.